Patents Assigned to Purecell Technologies Inc.
  • Publication number: 20080274217
    Abstract: The present invention provides a new use for a thylakoid extract, that is for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Besides the pharmaceutical use, the thylakoid extract enters the composition of food or food supplements, for its inocuity and its capacity to provide a diet enriched in anti-oxidants and anti-inflammatory compounds. Therefore, in accordance with the present invention is provided the use of a thylakoid extract in the making of an oral composition for treating or preventing a disease or disorder involving the formation of reactive oxygen species or inflammation. Also is provided a method for treating or preventing a disease or disorder involving the formal of reactive oxygen species or inflammation in an individual, which comprises the step of orally administering an effective dose of a thylakoid extract.
    Type: Application
    Filed: July 11, 2008
    Publication date: November 6, 2008
    Applicant: PURECELL TECHNOLOGIES INC.
    Inventors: Marc Purcell, Rejean Drouin
  • Patent number: 7329423
    Abstract: A thylakoid extract that is preferably stabilized and activable for treating inflammation is described. Different types of cell or tissue targets and inflammatory stimuli have been used to evaluate the performance of the extract, which, in all cases successfully modulate inflammation through a balance of pro/anti-inflammatory cytokines. Compositions comprising the extract and other anti-inflammatory agents, such as glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs) are further disclosed and claimed.
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: February 12, 2008
    Assignee: Purecell Technologies Inc.
    Inventors: Alain Andersen, Elyse Bissonnette, Rejean Drouin, Marc Purcell
  • Patent number: 7270839
    Abstract: This invention relates to a process by which an extract comprising integral thylakoids is obtained. The resulting extract is a potent dynamic antioxidant useful as a ROS (reactive oxygen species) scavenger. This extract is intended to be used for the treatment or prevention of diseases involving the generation of ROS, such as inflammatory diseases or cancer. This extract also finds a use as a solar screen because of its capacity to capture UV radiations and to dissipate the solar energy into heat.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: September 18, 2007
    Assignee: Purecell Technologies Inc.
    Inventor: Marc Purcell